|
US6479533B1
(en)
|
1997-02-20 |
2002-11-12 |
Applied Genetics Incorporated Dermatics |
Methods and compositions for the protection of mitochondria
|
|
JP2002501018A
(ja)
|
1998-01-26 |
2002-01-15 |
マイトコー |
ミトコンドリア関連疾患を処置するためのミトコンドリア保護剤
|
|
JP2001064158A
(ja)
*
|
1999-06-25 |
2001-03-13 |
Terumo Corp |
リポソーム
|
|
FR2809000B1
(fr)
*
|
2000-05-18 |
2002-08-09 |
Oreal |
Utilisation d'ergothioneine et/ou de ses derives comme agent anti-pollution
|
|
WO2001090332A2
(en)
|
2000-05-23 |
2001-11-29 |
The University Of Texas System |
Dna repair polypeptides and methods of use
|
|
US6733797B1
(en)
|
2000-11-15 |
2004-05-11 |
William K. Summers |
Neuroceutical for improving memory and cognitive abilities
|
|
AU2003230770A1
(en)
*
|
2002-03-28 |
2003-10-13 |
Oxis International, Inc. |
Neuroprotectant methods, compositions, and screening methods thereof
|
|
CA2527625A1
(en)
*
|
2003-05-30 |
2004-12-23 |
Alza Corporation |
Method of pulmonary administration of an agent
|
|
US20050042306A1
(en)
*
|
2003-08-21 |
2005-02-24 |
Christopher Marrs |
Stabilized compositions containing an oxygen-labile active agent
|
|
US20050042233A1
(en)
*
|
2003-08-21 |
2005-02-24 |
Christopher Marrs |
Stabilized compositions containing an oxygen-labile active agent and a fungal extract
|
|
FR2865398B1
(fr)
*
|
2004-01-23 |
2009-07-03 |
Jean Noel Thorel |
Compositions destinees a la protection cellulaire vis-a-vis des uva, de la peau, et/ou des phaneres.
|
|
CA2568201C
(en)
|
2004-05-24 |
2013-07-30 |
Universitat Zu Koln |
Identification of ergothioneine transporter and therapeutic uses thereof
|
|
US20070282318A1
(en)
*
|
2006-05-16 |
2007-12-06 |
Spooner Gregory J |
Subcutaneous thermolipolysis using radiofrequency energy
|
|
CA2680223C
(en)
*
|
2007-03-07 |
2012-05-08 |
Robert B. Beelman |
Use of ergothioneine as a preservative in foods and beverages
|
|
FR2915397B1
(fr)
|
2007-04-27 |
2012-01-20 |
Vincience |
Composition pharmaceutique et/ou cosmetique contenant des principes actifs activateurs de l'aconitase
|
|
FR2918893B1
(fr)
|
2007-07-20 |
2012-10-19 |
Vincience |
Utilisation d'un principe actif issu du lin pour preparer une composition destinee a activer le cytochrome c
|
|
US8257753B2
(en)
|
2007-07-20 |
2012-09-04 |
Isp Investments Inc. |
Use of an active principle originating from flax in a composition intended to reinforce the barrier function of the skin and to protect the skin and the appendages against external aggressions
|
|
US8563500B2
(en)
*
|
2007-09-05 |
2013-10-22 |
Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts |
Methods and compounds for treating diseases caused by reactive oxygen species
|
|
US7767826B2
(en)
*
|
2007-10-05 |
2010-08-03 |
Pharmatech International, Inc. |
Process for the synthesis of L-(+)-ergothioneine
|
|
FR2924334B1
(fr)
*
|
2007-11-30 |
2016-03-25 |
Lvmh Rech |
Composition cosmetique comprenant l'acide 2-glucoside ascorbique et l'ergothioneine.
|
|
EP3268354B1
(en)
|
2015-03-13 |
2020-05-06 |
Mironova Innovations, LLC |
Nalpha, nalpha, nalpha-trialkyl histidine derivatives useful for the preparation of ergothioneine compounds
|
|
US11376311B2
(en)
|
2017-11-02 |
2022-07-05 |
Colorado Seminary, Owner and Operator of University of Denver |
Methods of treating microbial infection and inflammation
|
|
WO2019173159A1
(en)
|
2018-03-05 |
2019-09-12 |
Mironova Innovations, Llc |
Ergothioneine compositions and methods for maintaining and/or increasing vitamin c levels in cells and organisms
|
|
US11013710B2
(en)
*
|
2018-12-05 |
2021-05-25 |
Celagenex Research (India) Pvt. Ltd. |
Synergistic compositions of bioactive agents for optimizing cellular health
|
|
EP3925636A1
(en)
*
|
2020-06-17 |
2021-12-22 |
Centre Of Experimental Medicine Slovak Academy Of Sciences Institute Of Experimental Pharmacology |
Composite membranes containing a smart-released cytoprotectant targeting the inflamed tissue and use thereof
|
|
CN112641777B
(zh)
*
|
2021-01-07 |
2023-02-03 |
山东华熙海御生物医药有限公司 |
麦角硫因类物质在制备防治缺血性脑卒中药物中的应用
|
|
EP4331582A4
(en)
|
2021-04-26 |
2025-04-09 |
Suntory Holdings Limited |
COMPOSITION FOR STIMULATING IMMUNE CELL METABOLISM
|
|
CN116390716A
(zh)
*
|
2021-06-22 |
2023-07-04 |
南京纽邦生物科技有限公司 |
L-麦角硫因用于改善和预防年龄相关的玻璃体变性
|
|
CN117580573A
(zh)
*
|
2021-06-22 |
2024-02-20 |
南京纽邦生物科技有限公司 |
L-麦角硫因用于缓解和预防年龄相关的视力退化
|
|
WO2023004608A1
(en)
*
|
2021-07-28 |
2023-02-02 |
Nanjing Nutrabuilding Bio-Tech Co., Ltd. |
L-ergothioneine and therapeutic uses thereof
|
|
CN118576592A
(zh)
*
|
2023-03-02 |
2024-09-03 |
中国科学院高能物理研究所 |
麦角硫因或其组合物在制备辐射防护剂中的应用
|
|
CN118121502B
(zh)
*
|
2024-01-25 |
2024-09-24 |
合肥和晨生物科技有限公司 |
麦角硫因组合物包埋递送制剂及其制备方法和应用
|